Download Our DHN Survey Result 2024
Exclusive
scalehealthtech Realize your Healthcare’s Digital Transformation journey with ScaleHealthTech Learn More

Neuberg Diagnostics Merges with a couple of Entities to Strengthen Position in Healthcare Sector

Written by : Aishwarya Sarthe

September 21, 2023

Category Img

Bringing together two well-known organisations under Neuberg Diagnostics aims to strengthen the foundation for achieving milestones, incorporating over 80% of the total group revenue.

Chennai-based Neuberg Diagnostics has merged with two institutes- Neuberg Supratech Reference Laboratory, Ahmedabad, and Neuberg Anand Reference Laboratory, Bengaluru. 

The strategic objective of this merger is to streamline operations and enhance efficiency, incorporating over 80% of the total group revenue.

Commenting about the merger and its implications, Dr. GSK Velu, chairman and MD of Neuberg Diagnostics, said, "This merger signifies a significant step in our journey to provide unparalleled healthcare solutions. By integrating these renowned laboratories, we reinforce our commitment to delivering excellence in diagnostics and patient care".

In light of this consolidation, Neuberg Diagnostics aims to achieve its target of achieving gross revenues exceeding  INR 1,000 Cr (US $120+ Mn) in the current fiscal year. 

Further, this merger enables the company to expand its range of diagnostic services across India and beyond.

Founded in 2017, Neuberg Diagnostics, runs Neuberg Centre for Genomics Medicine (NCGM) and Neuberg Centre for Proteomics & Metabolomics (NCPM). 

These centres position Neuberg at the forefront of personalised medicine innovation, particularly NCGM, which, the institute claims to have made significant strides in the genomic medicine market across South Asia, the Middle East, and Africa.

Following the merger, changes were made to Neuberg Diagnostics' senior management team as well. For example, Dr Sandip Shah was promoted to joint managing director, while Dr Sujay Prasad was promoted to chief medical director. Likewise, A. Ganesan will continue as vice chairman of Neuberg Diagnostics. 

Looking ahead, Neuberg Diagnostics plans to undertake an Initial Public Offering (IPO) in late 2024 or early 2025. This move aligns with the company's growth strategy and is expected to attract additional resources for operational expansion, thereby preserving its leadership position in diagnostic innovation.


ABOUT US

Digital Health News ( DHN) is India’s first dedicated digital health news platform launched by Industry recognized HealthTech Leaders. DHN Is Industry’s Leading Source Of HealthTech Business, Insights, Trends And Policy News.

DHN Provides In-Depth Data Analysis And Covers Most Impactful News As They Happen Across Entire Ecosystem Including Emerging Technology Trends And Innovations, Digital Health Startups, Hospitals, Health Insurance, Govt. Agencies & Policies, Pharmaceuticals And Biotech.

CONTACT US

© Digital Health News 2024